Letter

Bifidobacteria can protect from enteropathogenic infection through production of acetate

  • Nature volume 469, pages 543547 (27 January 2011)
  • doi:10.1038/nature09646
  • Download Citation
Received:
Accepted:
Published online:

Abstract

The human gut is colonized with a wide variety of microorganisms, including species, such as those belonging to the bacterial genus Bifidobacterium, that have beneficial effects on human physiology and pathology1,2,3. Among the most distinctive benefits of bifidobacteria are modulation of host defence responses and protection against infectious diseases4,5,6. Nevertheless, the molecular mechanisms underlying these effects have barely been elucidated. To investigate these mechanisms, we used mice associated with certain bifidobacterial strains and a simplified model of lethal infection with enterohaemorrhagic Escherichia coli O157:H7, together with an integrated ‘omics’ approach. Here we show that genes encoding an ATP-binding-cassette-type carbohydrate transporter present in certain bifidobacteria contribute to protecting mice against death induced by E. coli O157:H7. We found that this effect can be attributed, at least in part, to increased production of acetate and that translocation of the E. coli O157:H7 Shiga toxin from the gut lumen to the blood was inhibited. We propose that acetate produced by protective bifidobacteria improves intestinal defence mediated by epithelial cells and thereby protects the host against lethal infection.

  • Subscribe to Nature for full access:

    $199

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

Accessions

Primary accessions

Gene Expression Omnibus

Data deposits

Microarray data have been deposited in the NCBI Gene Expression Omnibus under accession number GSE13061. Sequences for the B. longum genomes have been deposited in the DNA Data Bank of Japan, GenBank and the EMBL Nucleotide Sequence Database under accession numbers AP010888, AP010889, AP010890, AP010891 and AP010892.

References

  1. 1.

    et al. Bifidobacteria as probiotic agents—physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22, 495–512 (2005)

  2. 2.

    et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nature Rev. Microbiol. 7, 61–71 (2009)

  3. 3.

    , , & Gut microbiota: a potential new territory for drug targeting. Nature Rev. Drug Discov. 7, 123–129 (2008)

  4. 4.

    & The love–hate relationship between bacterial polysaccharides and the host immune system. Nature Rev. Immunol. 6, 849–858 (2006)

  5. 5.

    , , & Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr. Opin. Biotechnol. 20, 135–141 (2009)

  6. 6.

    , & Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 4, e413 (2006)

  7. 7.

    , & Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect. Immun. 73, 2573–2585 (2005)

  8. 8.

    , & Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073–1086 (2005)

  9. 9.

    , & Daily bowel movements and Escherichia coli O157 infection. Arch. Dis. Child. 87, 335–336 (2002)

  10. 10.

    et al. Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect. Immun. 76, 3054–3063 (2008)

  11. 11.

    et al. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72, 2240–2247 (2004)

  12. 12.

    , , , & Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Int. J. Food Microbiol. 111, 26–33 (2006)

  13. 13.

    , & Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains. Antonie Van Leeuwenhoek 97, 107–117 (2010)

  14. 14.

    , , & Regulation of complement C3 expression by the bile acid receptor FXR. J. Biol. Chem. 280, 7427–7434 (2005)

  15. 15.

    et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl Acad. Sci. USA 98, 507–512 (2001)

  16. 16.

    , , , & Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochem. J. 376, 351–360 (2003)

  17. 17.

    & Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116, 607–614 (2006)

  18. 18.

    et al. Oxidized omega-3 fatty acids in fish oil inhibit leukocyte–endothelial interactions through activation of PPARα. Blood 100, 1340–1346 (2002)

  19. 19.

    et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393, 790–793 (1998)

  20. 20.

    , , & Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J. Biol. Chem. 275, 36703–36707 (2000)

  21. 21.

    et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl Acad. Sci. USA 105, 18964–18969 (2008)

  22. 22.

    et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl Acad. Sci. USA 99, 14422–14427 (2002)

  23. 23.

    et al. Sugar transport systems of Bifidobacterium longum NCC 2705. J. Mol. Microbiol. Biotechnol. 12, 9–19 (2007)

  24. 24.

    et al. A proteome reference map and proteomic analysis of Bifidobacterium longum NCC 2705. Mol. Cell. Proteomics 5, 1105–1118 (2006)

  25. 25.

    , & Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J. Nutr. 133, 3523–3528 (2003)

  26. 26.

    , , & Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 13, 2826–2832 (2007)

  27. 27.

    & Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure. Gastroenterology 130, S100–S105 (2006)

  28. 28.

    et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009)

  29. 29.

    et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14, 169–181 (2007)

  30. 30.

    , & Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins. J. Clin. Microbiol. 25, 115–118 (1987)

  31. 31.

    , , & Ingestion of resistant starch protects endotoxin influx from the intestinal tract and reduces d-galactosamine-induced liver injury in rats. J. Gastroenterol. Hepatol. 19, 303–313 (2004)

  32. 32.

    et al. Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS ONE 3, e3033 (2008)

  33. 33.

    et al. Distinct gene expression profiles characterize cellular phenotypes of follicle-associated epithelium and M cells. DNA Res. 12, 127–137 (2005)

  34. 34.

    et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003)

  35. 35.

    et al. Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells. Bioinformatics 23, 2934–2941 (2007)

  36. 36.

    et al. Top-down phenomics of Arabidopsis thaliana: metabolic profiling by one- and two-dimensional nuclear magnetic resonance spectroscopy and transcriptome analysis of albino mutants. J. Biol. Chem. 282, 18532–18541 (2007)

  37. 37.

    et al. Evaluation and characterization of bacterial metabolic dynamics with a novel profiling technique, real-time metabolotyping. PLoS ONE 4, e4893 (2009)

  38. 38.

    , & Stable isotope labeling of Arabidopsis thaliana for an NMR-based metabolomics approach. Plant Cell Physiol. 45, 1099–1104 (2004)

  39. 39.

    , & Profiling polar and semi-polar plant metabolites throughout extraction processes using a combined solution-state and HR-MAS NMR approach. Anal. Chem. 82, 1643–1652 (2010)

  40. 40.

    et al. PRIMe: a Web site that assembles tools for metabolomics and transcriptomics. In Silico Biol. 8, 339–345 (2008)

  41. 41.

    et al. Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal. Chem. 82, 1653–1658 (2010)

  42. 42.

    , & Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell. Microbiol. 6, 289–301 (2004)

  43. 43.

    , & Automated finishing with Autofinish. Genome Res. 11, 614–625 (2001)

  44. 44.

    , , , & Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27, 4636–4641 (1999)

  45. 45.

    & tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25, 955–964 (1997)

  46. 46.

    et al. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Biosci. Biotechnol. Biochem. 66, 2362–2366 (2002)

  47. 47.

    et al. Improvement of bacterial transformation efficiency using plasmid artificial modification. Nucleic Acids Res. 37, e3 (2009)

Download references

Acknowledgements

We thank H. Kitamura and M. E. Mariotti-Ferrandiz for discussions and for reading the manuscript; T. Morita for suggestions; and C. Nishigaki, M. Ohmae, Y. Chiba, T. Kato, H. Shima, A. Nakano, K. Sakaguchi, K. Furuya, C. Yoshino, H. Inaba, E. Iioka, K. Motomura and Y. Hattori for technical support. This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan: a Grant-in-Aid for Scientific Research on Priority Areas ‘Comprehensive Genomics’ (M.H.), ‘Membrane Traffic’ (H.O.) and ‘Matrix of Infectious Phenomena’ (K.H.); Young Scientists (S.F., K.H. and J.K.); Challenging Exploratory Research (J.K.); Scientific Research (H.O.); and Scientific Research on Innovative Areas ‘Intracellular Logistics’ (H.O.). This work was also supported in part by a RIKEN President’s Special Research Grant (J.K.); a RIKEN DRI Research Grant (S.F.); a CREST grant from the Japan Science and Technology Agency (J.K.); the Danone Institute of Japan (H.O.); the Institute for Fermentation, Osaka (S.F.); the Kieikai Research Foundation (S.F.); the Naito Foundation (S.F.); the Nestlé Nutrition Council, Japan (S.F.); the Sasakawa Scientific Research Grant from the Japan Science Society (S.F. and Y.N.); the Yakult Bio-Science Foundation (S.F.); the Academic Frontier Project for Private Universities (Matching Fund Subsidy (H.M.)); and the Private University Scientific Foundation (H.M.).

Author information

Affiliations

  1. Laboratory for Epithelial Immunobiology, RIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan

    • Shinji Fukuda
    • , Koji Hase
    • , Yumiko Nakanishi
    •  & Hiroshi Ohno
  2. Graduate School of Nanobioscience, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan

    • Shinji Fukuda
    • , Yumiko Nakanishi
    • , Jun Kikuchi
    •  & Hiroshi Ohno
  3. MetaSystems Research Team, RIKEN Advanced Science Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan

    • Hidehiro Toh
    •  & Todd D. Taylor
  4. Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan

    • Kenshiro Oshima
    •  & Masahira Hattori
  5. Advanced NMR Metabomics Research Team, RIKEN Plant Science Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan

    • Yumiko Nakanishi
    •  & Jun Kikuchi
  6. Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan

    • Kazutoshi Yoshimura
    •  & Kikuji Itoh
  7. Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan

    • Toru Tobe
  8. Preventative Health National Research Flagship, CSIRO Food and Nutritional Sciences, Adelaide, South Australia 5000, Australia

    • Julie M. Clarke
    •  & David L. Topping
  9. The United Graduate School of Agricultural Science, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan

    • Tohru Suzuki
  10. Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan

    • Jun Kikuchi
  11. School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 229-8501, Japan

    • Hidetoshi Morita
  12. Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan

    • Hiroshi Ohno

Authors

  1. Search for Shinji Fukuda in:

  2. Search for Hidehiro Toh in:

  3. Search for Koji Hase in:

  4. Search for Kenshiro Oshima in:

  5. Search for Yumiko Nakanishi in:

  6. Search for Kazutoshi Yoshimura in:

  7. Search for Toru Tobe in:

  8. Search for Julie M. Clarke in:

  9. Search for David L. Topping in:

  10. Search for Tohru Suzuki in:

  11. Search for Todd D. Taylor in:

  12. Search for Kikuji Itoh in:

  13. Search for Jun Kikuchi in:

  14. Search for Hidetoshi Morita in:

  15. Search for Masahira Hattori in:

  16. Search for Hiroshi Ohno in:

Contributions

S.F., K.I., M.H. and H.O. conceived and designed the experiments. S.F., Y.N., K.H., K.Y., K.O., H.M. and K.I. performed the experiments. S.F., H.T. and Y.N. analysed the data. T.T., J.M.C., D.L.T., T.S., T.D.T., J.K. and M.H. contributed reagents, materials and analysis tools. S.F., H.T., K.H., T.D.T., M.H. and H.O. wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Masahira Hattori or Hiroshi Ohno.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    The file contains Supplementary Figures 1-12 with legends and Supplementary Tables 1-12.

Excel files

  1. 1.

    Supplementary Table 13

    This table contains 1H NMR profiling raw data.

  2. 2.

    Supplementary Table 14

    This table contains 1H-13C correlation NMR profiling raw data.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.